🟢 At a Glance:
Tan Kok Hui, a shareholder from Malaysia, just pulled a “Sorry bro, wrong form” moment with the SEC. He mistakenly filed a Form 3 (used only by company insiders like directors and 10%+ owners) for Cyclacel Pharmaceuticals (NASDAQ: CYCC)… even though he’s none of those things.
The result? A Form 3/A (amendment) saying: “My bad, I’m just a regular shareholder. Please ignore.”
💊 The Curious Case of CYCC and the Malaysian Phantom Insider
| 🧾 | Details |
|---|---|
| 👤 Name | Tan Kok Hui |
| 🏢 Company | Cyclacel Pharmaceuticals, Inc. |
| 🧪 Ticker | CYCC |
| 🗓️ Original Form 3 Filed | May 14, 2025 |
| 🔁 Amended on | May 30, 2025 |
| 📦 Shares Owned | Zero (0) |
| 🎭 Declared Role | Not an officer, not a director, not even a 10% owner |
| ✍️ Signed Off | “Oops, not me” — /s/ Tan Kok Hui |
🚨 What Happened?
- Mr. Tan (probably jetlagged from a flight to KL) mistakenly filed a Form 3 with the SEC.
- That form is reserved for insiders of a public company — typically big wigs or people who can tank the stock price with a tweet.
- SEC filings aren’t your neighborhood WhatsApp forwards — they trigger real legal tracking, compliance flags, and occasionally, Twitter finance bros screaming “insider alert!”
🧠 Actual Reason for the Amendment
Here’s the official translation of the legalese:
“I, Tan Kok Hui, am not a director, officer, or 10%+ owner of Cyclacel Pharmaceuticals. My Form 3 was filed by accident. Please stop looking at me like I’m Carl Icahn.”
🩺 About Cyclacel Pharmaceuticals (CYCC)
- US-based oncology biotech firm working on cell cycle-based cancer treatments.
- Currently has a market cap of around $10M–$15M. (Yes, that’s M, not B.)
- Stock mostly trades like a penny stock — volatile, low volume, and perfect for mysterious filing mix-ups.
- Their last big milestone was surviving 2023.
🪞 The Real Joke?
Imagine telling the world you’re an “insider” at a tiny pharma company, filing it with a federal regulator, only to later go:
“Oops, clicked the wrong PDF.”
It’s like RSVP-ing to your ex’s wedding by mistake. Publicly. In front of their lawyer.
And the DJ.
And their hedge fund.
📊 Does This Affect CYCC Stock?
Let’s be honest: probably not.
The company barely trades a few thousand shares on a good day. This filing is more of a footnote in the SEC’s meme folder than a catalyst for price action.
But for compliance nerds? This is chef’s kiss comedy.
🔚 EduInvesting Verdict
“Not every shareholder is an insider.
But every insider should know if they are one.”
Tan Kok Hui just got a crash course in US securities law. And maybe a follow-up from his lawyer with a subject line:
“WHY DID YOU FILE A FORM 3???”
🗓️ Filed: May 30, 2025
✍️ Author: Prashant Marathe
🏷️ Tags: CYCC, Cyclacel, SEC Filing, Form 3/A, Insider Error, Tan Kok Hui, Pharma Stocks, Finance Satire, EduInvesting Roast
